Martin J Driscoll is President and CEO of F-star Therapeutics, Inc.. Currently has a direct ownership of 47,425 shares of FSTX, which is worth approximately $0. The most recent transaction as insider was on Nov 20, 2020, when has been sold 175 shares (Common Stock) at a price of $4.76 per share, resulting in proceeds of $833. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 47.4K
0% 3M change
0% 12M change
Total Value Held $0

Martin J Driscoll Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 20 2020
SELL
Open market or private sale
$833 $4.76 p/Share
175 Reduced 0.37%
47,425 Common Stock
Nov 19 2020
BUY
Grant, award, or other acquisition
-
15,000 Added 23.96%
47,600 Common Stock
Nov 19 2020
BUY
Exercise of conversion of derivative security
-
10,000 Added 23.47%
32,600 Common Stock
MJD

Martin J Driscoll

President and CEO
Hopkinton, MA

Track Institutional and Insider Activities on FSTX

Follow F-star Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FSTX shares.

Notify only if

Insider Trading

Get notified when an F Star Therapeutics, Inc. insider buys or sells FSTX shares.

Notify only if

News

Receive news related to F-star Therapeutics, Inc.

Track Activities on FSTX